Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Similar articles for PubMed (Select 25065359)

1.

Surgical management of advanced gastrointestinal stromal tumors: an international multi-institutional analysis of 158 patients.

Bischof DA, Kim Y, Blazer DG 3rd, Behman R, Karanicolas PJ, Law CH, Quereshy FA, Maithel SK, Gamblin TC, Bauer TW, Pawlik TM.

J Am Coll Surg. 2014 Sep;219(3):439-49. doi: 10.1016/j.jamcollsurg.2014.02.037. Epub 2014 May 22.

PMID:
25065359
2.

Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors.

Bednarski BK, Araujo DM, Yi M, Torres KE, Lazar A, Trent JC, Cormier JN, Pisters PW, Lev DC, Pollock RE, Feig BW, Hunt KK.

Ann Surg Oncol. 2014 Aug;21(8):2499-505. doi: 10.1245/s10434-014-3632-7. Epub 2014 Mar 18.

PMID:
24639192
3.

Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.

Cao H, Zhang Y, Wang M, Shen DP, Sheng ZY, Ni XZ, Wu ZY, Liu Q, Shen YY, Song YY.

Chin Med J (Engl). 2010 Jan 20;123(2):131-6.

PMID:
20137358
4.

Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.

Turley RS, Peng PD, Reddy SK, Barbas AS, Geller DA, Marsh JW, Tsung A, Pawlik TM, Clary BM.

Cancer. 2012 Jul 15;118(14):3571-8. doi: 10.1002/cncr.26650. Epub 2011 Nov 15.

5.

Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.

Hassan I, You YN, Shyyan R, Dozois EJ, Smyrk TC, Okuno SH, Schleck CD, Hodge DO, Donohue JH.

Ann Surg Oncol. 2008 Jan;15(1):52-9. Epub 2007 Nov 14.

PMID:
18000711
6.

Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.

Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C.

Anticancer Drugs. 2008 Jul;19(6):607-12. doi: 10.1097/CAD.0b013e32830138f9.

PMID:
18525320
7.

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial.

Blesius A, Cassier PA, Bertucci F, Fayette J, Ray-Coquard I, Bui B, Adenis A, Rios M, Cupissol D, Pérol D, Blay JY, Le Cesne A.

BMC Cancer. 2011 Feb 15;11:72. doi: 10.1186/1471-2407-11-72.

8.

Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.

Tielen R, Verhoef C, van Coevorden F, Gelderblom H, Sleijfer S, Hartgrink HH, Bonenkamp JJ, van der Graaf WT, de Wilt JH.

Eur J Surg Oncol. 2013 Feb;39(2):150-5. doi: 10.1016/j.ejso.2012.09.004. Epub 2012 Oct 16.

9.

Role of operative therapy in treatment of metastatic gastrointestinal stromal tumors.

Zaydfudim V, Okuno SH, Que FG, Nagorney DM, Donohue JH.

J Surg Res. 2012 Oct;177(2):248-54. doi: 10.1016/j.jss.2012.07.005. Epub 2012 Jul 20.

PMID:
22831567
10.

Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.

Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW.

Ann Surg Oncol. 2007 Jan;14(1):14-24.

PMID:
17072676
11.

Open versus minimally invasive resection of gastric GIST: a multi-institutional analysis of short- and long-term outcomes.

Bischof DA, Kim Y, Dodson R, Carolina Jimenez M, Behman R, Cocieru A, Blazer DG 3rd, Fisher SB, Squires MH 3rd, Kooby DA, Maithel SK, Groeschl RT, Clark Gamblin T, Bauer TW, Karanicolas PJ, Law C, Quereshy FA, Pawlik TM.

Ann Surg Oncol. 2014 Sep;21(9):2941-8. doi: 10.1245/s10434-014-3733-3. Epub 2014 Apr 24.

PMID:
24763984
12.

Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.

Jakob J, Mussi C, Ronellenfitsch U, Wardelmann E, Negri T, Gronchi A, Hohenberger P.

Ann Surg Oncol. 2013 Feb;20(2):586-92. doi: 10.1245/s10434-012-2647-1. Epub 2012 Sep 11.

PMID:
22965573
13.

External beam radiation therapy for locally advanced and metastatic gastrointestinal stromal tumors.

Cuaron JJ, Goodman KA, Lee N, Wu AJ.

Radiat Oncol. 2013 Nov 23;8:274. doi: 10.1186/1748-717X-8-274.

14.

[Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].

Liang YM, Li XH, Lü YY, Lü YL, Zhong M, Pu XL, Li WM.

Zhonghua Bing Li Xue Za Zhi. 2007 Apr;36(4):233-8. Chinese.

PMID:
17706113
15.

Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.

Rutkowski P, Gronchi A, Hohenberger P, Bonvalot S, Schöffski P, Bauer S, Fumagalli E, Nyckowski P, Nguyen BP, Kerst JM, Fiore M, Bylina E, Hoiczyk M, Cats A, Casali PG, Le Cesne A, Treckmann J, Stoeckle E, de Wilt JH, Sleijfer S, Tielen R, van der Graaf W, Verhoef C, van Coevorden F.

Ann Surg Oncol. 2013 Sep;20(9):2937-43. doi: 10.1245/s10434-013-3013-7. Epub 2013 Jun 13.

PMID:
23760587
16.

An audit of surgical management of gastrointestinal stromal tumours (GIST).

Bucher P, Egger JF, Gervaz P, Ris F, Weintraub D, Villiger P, Buhler LH, Morel P.

Eur J Surg Oncol. 2006 Apr;32(3):310-4. Epub 2006 Jan 18.

PMID:
16414236
17.

Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST).

Hohenberger P, Eisenberg B.

Ann Surg Oncol. 2010 Oct;17(10):2585-600. doi: 10.1245/s10434-010-1053-9. Epub 2010 Apr 21.

PMID:
20407930
18.

Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis.

Johnston FM, Kneuertz PJ, Cameron JL, Sanford D, Fisher S, Turley R, Groeschl R, Hyder O, Kooby DA, Blazer D 3rd, Choti MA, Wolfgang CL, Gamblin TC, Hawkins WG, Maithel SK, Pawlik TM.

Ann Surg Oncol. 2012 Oct;19(11):3351-60. doi: 10.1245/s10434-012-2551-8. Epub 2012 Aug 10.

PMID:
22878613
19.

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).

Dematteo RP, Gold JS, Saran L, Gönen M, Liau KH, Maki RG, Singer S, Besmer P, Brennan MF, Antonescu CR.

Cancer. 2008 Feb 1;112(3):608-15.

20.

Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.

Joensuu H, Vehtari A, Riihimäki J, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson MK, Linke Z, Sufliarsky J, Federico M, Jonasson JG, Dei Tos AP, Rutkowski P.

Lancet Oncol. 2012 Mar;13(3):265-74. doi: 10.1016/S1470-2045(11)70299-6. Epub 2011 Dec 6. Review.

PMID:
22153892
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk